[Angiotensin-converting enzyme inhibitors in the diagnosis and treatment of kidney diseases].
The authors describe in a review the use of inhibitors of the angiotensin converting enzyme, in particular enalapril, in the treatment of nephrogenic hypertension, glomerulopathies without hypertension, renovascular hypertension with unilateral or bilateral stenosis of the renal artery and diabetic nephropathy. They draw attention to specific traits in the treatment of different disorders, risk of treatment and the ensuing tactics of indication, dosage and monitoring.
Dzúrik
R
R
Centrum klinickej farmakológie Ustavu preventívnej a klinickej medicíny, Bratislava.
Dzúriková
V
V
Stefíková
K
K
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D006978:Hypertension, Renovascular / Q000175:diagnosis / Q000188:drug therapy; D007674:Kidney Diseases / Q000175:diagnosis / Q000188:drug therapy*
D000806:Angiotensin-Converting Enzyme Inhibitors
Inhibítory angiotenzín konvertujúceho enzýmu v diagnostike a v liecbe chorôb obliciek.